Vivani Medical Appoints Daniel Bradbury to its Board of Directors [Yahoo! Finance]
Vivani Medical, Inc. (VANI)
Company Research
Source: Yahoo! Finance
Under Bradbury's leadership as CEO, Amylin Pharmaceuticals, with partner Alkermes, secured in 2012 approval of Bydureon® (exenatide injection), the world's first once-weekly GLP-1 receptor agonist, a class of drugs that now includes blockbusters Ozempic®, Trulicity®, and Wegovy® ALAMEDA, Calif., March 06, 2024 BUSINESS WIRE )--Vivani Medical, Inc. (Nasdaq: VANI ) ("Vivani" or the "Company"), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today announced the appointment of long-time industry veteran Daniel Bradbury to its Board of Directors. "Dan has served as an advisor to Vivani and our legacy company, Nano Precision Medical, since 2017, and his guidance has been invaluable," said Adam Mendelsohn, Ph.D., Vivani President and Chief Executive Officer. "As a member of Vivani's distinguished board of directors, Dan's leadership expertise and deep insight and experience developing and commercializing the world's first GLP-1 drug
Show less
Read more
Impact Snapshot
Event Time:
VANI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VANI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VANI alerts
High impacting Vivani Medical, Inc. news events
Weekly update
A roundup of the hottest topics
VANI
News
- Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsBusiness Wire
- Vivani Medical Appoints Daniel Bradbury to its Board of DirectorsBusiness Wire
- Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants [Yahoo! Finance]Yahoo! Finance
- Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and WarrantsBusiness Wire
VANI
Sec Filings
- 4/29/24 - Form ARS
- 4/29/24 - Form DEFA14A
- 4/29/24 - Form DEF
- VANI's page on the SEC website